{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:17:36Z","timestamp":1790781456265,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clml.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T05:06:08Z","timestamp":1602219968000},"page":"205-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center"],"prefix":"10.1016","volume":"21","author":[{"given":"Andrew","family":"Tiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djeneba Audrey","family":"Djibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorab","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Alpdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.10.003_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2020.10.003_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3322\/caac.21555","article-title":"Cancer statistics for African Americans, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2020.10.003_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.10.003_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clml.2020.10.003_bib5","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clml.2011.03.012","article-title":"Outcome of diffuse large B-cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data","volume":"11","author":"Komrokji","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.10.003_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/1471-2407-10-625","article-title":"Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)","volume":"10","author":"Griffiths","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/10428194.2012.708751","article-title":"Examining racial differences in diffuse large B-cell lymphoma presentation and survival","volume":"54","author":"Flowers","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.10.003_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clml.2015.06.005","article-title":"Persistent disparities among patients with T-cell non-Hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: a SEER database review","volume":"15","author":"Crozier","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.10.003_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/17474086.2016.1146584","article-title":"Diffuse large B-cell lymphoma: prognostic markers and their impact on therapy","volume":"9","author":"Jamil","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.clml.2020.10.003_bib11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A\u00a0predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.10.003_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.10.003_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajh.10391","article-title":"Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma","volume":"74","author":"M\u00f8ller","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.10.003_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","article-title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","volume":"123","author":"Zhou","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib16","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/bloodadvances.2019000251","article-title":"COO and MYC\/BCL2 status do not predict outcome among patients with stage I\/II DLBCL: a retrospective multicenter study","volume":"3","author":"Barraclough","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2020.10.003_bib17","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1200\/JCO.2014.60.2383","article-title":"Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies","volume":"33","author":"Scott","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.10.003_bib18","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-11-0267","article-title":"BCL2 predicts survival in germinal center B-cell\u2013like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab","volume":"17","author":"Iqbal","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clml.2020.10.003_bib19","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V98.4.945","article-title":"Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma","volume":"98","author":"Lossos","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib21","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V126.23.1460.1460","article-title":"Differences in cell of origin (COO) affect outcomes in Caucasian (C) but not in African American (AA) patients with diffuse large B-cell lymphoma (DLBCL)","volume":"126","author":"Borate","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1200\/EDBK_175444","article-title":"Health disparities and the global landscape of lymphoma care today","volume":"37","author":"Phillips","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clml.2020.10.003_bib23","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib24","series-title":"Race and Ethnic Standards for Federal Statistics and Administrative Reporting. Directive No. 15","author":"Office of Management and Budget (OMB)","year":"1997"},{"key":"10.1016\/j.clml.2020.10.003_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib26","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2020.10.003_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0148607112440285","article-title":"Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)","volume":"36","author":"White","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clml.2020.10.003_bib28","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973-2003","volume":"19","author":"Han","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2020.10.003_bib29","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/10428194.2015.1083098","article-title":"Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma","volume":"57","author":"Chen","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.10.003_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.21037\/aol.2017.11.01","article-title":"Disparities in lymphoma on the basis of race, gender, HIV status, and sexual orientation","volume":"1","author":"Becnel","year":"2017","journal-title":"Ann Lymphoma"},{"key":"10.1016\/j.clml.2020.10.003_bib31","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V110.11.3578.3578","article-title":"Race and non-Hodgkin\u2019s lymphoma: adverse impact of race and treatment delays on survival. A SEER-Medicare population study (1995, 2003)","volume":"110","author":"Vance","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.003_bib32","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3109\/10428194.2014.940583","article-title":"Disparities in receipt of radiotherapy and survival by age, sex and ethnicity among patients with stage I diffuse large B-cell lymphoma","volume":"56","author":"Shah","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.10.003_bib33","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/cncr.23914","article-title":"Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma","volume":"113","author":"Wang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib34","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2217\/fon.15.144","article-title":"Next-generation prognostic assessment for diffuse large B-cell lymphoma","volume":"11","author":"Staton","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.clml.2020.10.003_bib35","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00277-013-1807-0","article-title":"Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era","volume":"92","author":"Huang","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.10.003_bib36","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.3892\/ol.2017.6577","article-title":"BCL2\/Ki-67 index predict survival in germinal center B-cell\u2013like diffuse large B-cell lymphoma","volume":"14","author":"Tang","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clml.2020.10.003_bib37","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/cncr.30112","article-title":"Human immunodeficiency virus\u2013associated lymphomas in the antiretroviral therapy era: analysis of the National Cancer Data Base","volume":"122","author":"Olszewski","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib38","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cncr.30052","article-title":"Disparities in cancer treatment among patients infected with the human immunodeficiency virus","volume":"122","author":"Suneja","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3322\/caac.21359","article-title":"Disparities found in chemotherapy administration for human immunodeficiency virus\u2013associated lymphoma","volume":"67","author":"Barton","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2020.10.003_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"De Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2020.10.003_bib41","first-page":"31","article-title":"Malnutrition as an adverse prognostic factor in patients with diffuse large cell lymphoma","volume":"26","author":"Aviles","year":"1995","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clml.2020.10.003_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/01635581.2014.867065","article-title":"Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"66","author":"Park","year":"2014","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clml.2020.10.003_bib43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/CBM-170754","article-title":"Geriatric nutritional risk index is not an independent predictor in patients with diffuse large B-cell lymphoma","volume":"21","author":"Li","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.clml.2020.10.003_bib44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00277-018-3273-1","article-title":"Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma","volume":"97","author":"Kanemasa","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.10.003_bib45","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0609.2012.01778.x","article-title":"High Ki-67 expression in diffuse large B-cell lymphoma patients with non-germinal center subtype indicates limited survival benefit from R-CHOP therapy","volume":"88","author":"Li","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2020.10.003_bib46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5045\/br.2013.48.4.266","article-title":"Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma","volume":"48","author":"Hwang","year":"2013","journal-title":"Blood Res"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:35:46Z","timestamp":1730529346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020305553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2152265020305553"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.10.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival Disparities of Diffuse Large B-Cell Lymphoma in a Community-Based Inner-City Cancer Center","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}